Thymosin Alpha-1
Also called TA-1, thymalfasin, Zadaxin
Thymosin Alpha-1 is your immune system's coach.
This one has been through full clinical trials and is an approved medicine somewhere in the world. The ranges below are drawn from those trials and from what the community reports using.
- Immune
- Recovery & injury
The quick answer
Thymosin Alpha-1 is your immune system's coach. It's a natural thymic peptide that helps a run-down immune system respond better and helps an overactive one settle down - restoring balance rather than just revving things up. It's actually sold as a pharmaceutical (Zadaxin) in several countries.
The benefit builds slowly - most people notice it over two to four weeks, showing up as fewer sick days and quicker recovery rather than an acute effect. It's dosed steadily over a cycle. A nice thing here: it's one of the better-evidenced peptides on the list, though results are hard to feel directly - many judge it by how they made it through cold season.
Why people use it
🛡️ Strengthens a run-down immune system; ⚖️ Calms an overactive one; 🤒 Fewer sick days; 🏃 Faster recovery; 🔬 One of the best-evidenced peptides
What people report using
These are ranges other people have reported running. They are here so you can see what has actually been done — they are not medical advice and not a recommendation for you.
- How often
- Mon and Thu
- Route
- subcutaneous
- Evidence for this
- Approved medicine
Fewer things going around sticking, and shorter ones when they do.
10mg vial + 2ml BAC water = 5mg/ml. 1.6mg = 32u (0.32ml). twice a week (Monday and Thursday).
Work out your own units on the reconstitution calculator — the most common serious mistake in this area is arithmetic, not chemistry.
What to expect, and when
- First thing people notice
- Weeks 1–2 (resilience)
- When it gets real
- Weeks 3–4 (immune markers)
- Where it peaks
- Weeks 6–8 (steady state)
- Patience needed
- Medium - immune builds slowly
- Days 1–5Immune signaling engaged
Thymosin alpha-1 is studied as an immune modulator that acts through Toll-like receptors on dendritic cells and influences T-cell maturation. In the first days the described activity is at the signaling level, not something you feel. Users typically report no obvious change yet. Immune effects build rather than switch on.
- Weeks 1–2Early resilience reported
Users commonly report a subjective sense of resilience - feeling less run-down - in the first week or two, though this is anecdotal and hard to separate from expectation. Research suggests the peptide nudges immune-cell proliferation and activation over time. Meaningful marker changes generally lag felt changes. Frame this as preliminary, individual-level observation.
- Weeks 3–4Immune markers shift
Clinical research describes changes in immune parameters such as CD4+ counts and the CD4+/CD8+ ratio over a course of dosing. This is the window where measurable immune effects are more often documented in trials. It reflects a modulating, homeostasis-restoring action rather than blunt stimulation. Any real assessment here would rely on labs, not feel.
- Weeks 6–8Steady state
Reviews and trials generally evaluate thymosin alpha-1 over multi-week courses, with effects on immune homeostasis accruing toward a steadier state by roughly weeks 6–8. In a research context this is where the modulatory picture is fullest. Responses vary by individual and baseline immune status. It is approved in some countries but not the U.S. - this is educational context, not medical advice.
Studied mainly in specific clinical populations (e.g., certain infections); benefits in healthy individuals are not established, and it is not FDA-approved.
Side effects, and what people do about them
One of the best-tolerated here - it's even sold as a pharmaceutical in several countries. Most people notice little more than mild site redness, maybe a touch of tiredness as the immune system finds its balance. If you have an autoimmune condition or take immune-related medication, a quick check with your doctor first is all it takes.
Go deeper
Open these only if you want them.
How it actually works
Twenty-eight-amino-acid peptide from the thymus. It acts on Toll-like receptors 2 and 9 on dendritic cells and macrophages, maturing them and shifting the T-cell response - it modulates immune signalling rather than suppressing or stimulating it wholesale.
For stacking, the correction worth making every time it comes up: thymosin alpha-1 and thymosin beta-4 - the parent of TB-500 - share a name and almost nothing else. Alpha-1 is immune signalling; beta-4 sequesters actin and is structural, working on cell migration and tissue repair. People substitute one for the other on the strength of the shared word.
What people report, in full
The most repeated theme with Thymosin Alpha-1 isn't dose - it's sourcing. Because it's subtle and cumulative, a warm-shipped or degraded vial is the number-one reason behind "I felt nothing" reports. Among people with good product, the benefit shows up over three to six weeks as fewer sick days and faster recovery ("recovered from a cold in three days instead of seven"). The mainstream dose is a modest 1.6 mg twice a week; people who push higher generally report no extra benefit, just more injection-site irritation. It's one of the better-evidenced peptides, but the effects are quiet by nature.
Sources and review
https://pubmed.ncbi.nlm.nih.gov/23327199/
https://pubmed.ncbi.nlm.nih.gov/39814420/
https://pubmed.ncbi.nlm.nih.gov/9581695/
Last reviewed 2026-09-06.
People also look at
Still not sure?
Ask it the way you would ask a person. Follow-up questions are the point — it remembers what you already said.
Ask about Thymosin Alpha-1